PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+38.02%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.72B
AUM Growth
+$1.72B
(+30%)
Cap. Flow
-$5.61M
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
68.24%
Holding
45
New
–
Increased
23
Reduced
7
Closed
3
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$27.2M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$22.3M |
| 3 |
Amicus Therapeutics
FOLD
|
$12.4M |
| 4 |
Prothena Corp
PRTA
|
$8.75M |
| 5 |
United Therapeutics
UTHR
|
$5.29M |
Top Sells
| 1 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$25.4M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
$23.5M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$16.5M |
| 4 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
$15.8M |
| 5 |
SQNM
SEQUENOM INC NEW
SQNM
|
$9.43M |
Sector Composition
| 1 | Healthcare | 94.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $242M | 14.07% | 1,884,384 -182,535 | -9% | -$23.5M |
|
|
2
United Therapeutics
UTHR
$13.8B
| $208M | 12.1% | 1,763,458 +44,800 | +3% | +$5.29M |
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $166M | 9.62% | 1,790,899 +53,500 | +3% | +$4.95M |
|
|
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
| $137M | 7.97% | 3,804,088 | – | – |
|
|
AMAG
5
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $81.5M | 4.74% | 3,326,720 +53,500 | +2% | +$1.31M |
|
6
Insmed
INSM
$28.8B
| $73.9M | 4.29% | 5,091,298 +36,585 | +0.7% | +$531K |
|
|
CEMP
7
DELISTED
Cempra, Inc.
CEMP
| $68.8M | 4% | 2,844,483 +56,941 | +2% | +$1.38M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $68.8M | 4% | 561,700 +222,300 | +65% | +$27.2M |
|
9
Vanda Pharmaceuticals
VNDA
$279M
| $68.4M | 3.97% | 4,110,708 -114,900 | -3% | -$1.91M |
|
|
WMGI
10
DELISTED
Wright Medical Group Inc
WMGI
| $59.9M | 3.48% | 2,440,493 +32,100 | +1% | +$787K |
|
|
11
Prothena Corp
PRTA
$441M
| $56M | 3.26% | 934,455 +145,837 | +18% | +$8.75M |
|
|
ZLTQ
12
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $55.5M | 3.22% | 1,414,563 +23,484 | +2% | +$921K |
|
13
Acadia Pharmaceuticals
ACAD
$4.38B
| $47.1M | 2.74% | 1,481,930 +44,200 | +3% | +$1.41M |
|
|
14
Amicus Therapeutics
FOLD
$2.34B
| $42.1M | 2.44% | 5,685,388 +1,676,013 | +42% | +$12.4M |
|
|
SAGE
15
DELISTED
Sage Therapeutics
SAGE
| $41.5M | 2.41% | 902,051 +484,173 | +116% | +$22.3M |
|
|
ARIA
16
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $35.4M | 2.06% | 2,587,617 +52,500 | +2% | +$719K |
|
|
CELG
17
DELISTED
Celgene Corp
CELG
| $30.6M | 1.78% | 292,700 +13,100 | +5% | +$1.37M |
|
18
STAAR Surgical
STAA
$1.36B
| $30.5M | 1.77% | 3,244,610 +37,400 | +1% | +$352K |
|
19
Karyopharm Therapeutics
KPTI
$61.7M
| $30M | 1.74% | 3,085,849 -53,584 | -2% | -$521K |
|
|
EPZM
20
DELISTED
Epizyme, Inc
EPZM
| $27.7M | 1.61% | 2,814,540 +103,159 | +4% | +$1.02M |
|
21
Gilead Sciences
GILD
$140B
| $25.2M | 1.46% | 318,400 | – | – |
|
|
SHPG
22
DELISTED
Shire pic
SHPG
| $23.9M | 1.39% | 123,200 +3,900 | +3% | +$756K |
|
|
MNTA
23
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $19.3M | 1.12% | 1,650,876 +21,800 | +1% | +$255K |
|
|
ENDP
24
DELISTED
Endo International plc
ENDP
| $19M | 1.11% | 945,330 +22,100 | +2% | +$445K |
|
25
Rigel Pharmaceuticals
RIGL
$697M
| $19M | 1.11% | 5,186,088 -200,446 | -4% | -$736K |
|